Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Hereditary Thyroid Cancer Panel Genetic Services Laboratory University of Chicago United States | 11 | 13 |
|
Comprehensive Hereditary Cancer Panel Blueprint Genetics Finland | 14 | 146 |
|
Invitae Pediatric Solid Tumors Panel Invitae United States | 90 | 48 |
|
Invitae United States | 1 | 1 |
|
Fulgent Genetics United States | 70 | 26 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 329 | 127 |
|
Comprehensive Hereditary Cancer Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 128 | 130 |
|
Hereditary Breast/Gyn Cancer Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 28 | 28 |
|
Invitae United States | 139 | 80 |
|
CeGaT GmbH Germany | 20 | 18 |
|
Bioarray Spain | 1 | 1 |
|
Asper Biogene Asper Biogene LLC Estonia | 135 | 98 |
|
Fulgent Genetics United States | 1 | 1 |
|
Chromosomal Instability Syndromes NGS Panel Fulgent Genetics United States | 16 | 7 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
International Registry of Werner Syndrome University Of Washington United States | 1 | 1 |
|
International Registry of Werner Syndrome University Of Washington United States | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.